期刊文献+

几种类风湿关节炎吸附剂的制备及吸附性能比较 被引量:1

Preparation and Adsorption Capability of Several Adsorbents for Rheumatoid Arthritis
在线阅读 下载PDF
导出
摘要 制备了5种不同的类风湿关节炎吸附剂.用它们与类风湿关节炎病人血清作静态吸附实验,EL ISA检测吸附前后血清中RF s的浓度变化.实验发现,以纤维素球为载体,环氧氯丙烷活化后固定苯丙氨酸为配基的吸附剂综合吸附效果最好.该吸附剂对病人血清中IgGRF,IgM RF,IgARF的吸附中分别为39.3%,56.0%,28.1%.血液相容性实验结果显示,该吸附剂的血液相容性良好,能够满足临床应用要求.本文还研究了手臂对吸附剂吸附性能的影响,静态吸附实验结果显示PEG 4000为手臂的吸附剂吸附性能要高于以1,4-丁二醇二缩水甘油醚为手臂的吸附剂. Five different adsorbents i. e. cellulose beads as carrier, Phe or calf thymus DNA as ligand for the removal of rheumatoid factors (RFs) were prepared. Static adsorption experiments were conducted with the serum of RA patient, and the changes in concentration of Rheumatoid factors (RFs) were evaluated by ELISA. The results showed that the adsorbent with phenylalanine directly linked to the cellulose beads via epichlordrin had the highest adsorption capability than all the others. The concentration of IgGRF before adsorption was 524.6 IU/mL, after adsorption that was 318. 4 IU/mL, and the degree of removal was 39.3 % The concentration of IgMRF before adsorption was 805.6 IU/mL, after adsorption was 354.3 IU/mL, the degree of removal was 56.0 %; The concentration of IgARF before ad- sorption was 198.5 IU/mL, after adsorption was 142.8 IU/mL, the degree of removal was 28.1%. From the above results of investigation and other experiments, it is considered that hydrophobicity is important in the reaction between the RFs and Phe. Blood compatibility properties was studied on animal (rabbit) model, the results showed that no significant decrease of blood components occured. Preliminary studies on spacers showed that the PEG4000 spacer has a higher adsorption capability compared to the 1,4-butandioldiglycidylether spacer.
出处 《南开大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第5期79-85,共7页 Acta Scientiarum Naturalium Universitatis Nankaiensis
基金 国家"973"项目(G1999064707)
关键词 类风湿关节炎 吸附剂 制备 手臂 吸附性能 rheumatoid arthriis adsorbent preparation spacer adsorption capability
  • 相关文献

参考文献9

  • 1Brian Sutton, Adam Corper. Vincent bonagure and micheal taussig, the stucture and origin of rheumatoid factors[J]. Immunology Today, 2000, 15(2): 177-183.
  • 2Yamazaki Z. Efficiency and biocompatibility of a new immunoadsorbent[J]. Trans Am Soc Artif Inter Organs,1982,28(1) :318.
  • 3Kold G. Rapid adsorption of RF on suspension of glutaradehype crosslink IgG-a method to avoid RF interference[J].Biomat Art Cell Art Org, 1990, 18(5):605.
  • 4Joseph P, Balint Jr. Immune Modulation Associated with extracoporeal immunoadsorption treatment utilizing protein A/silica columns[J].Artificial Organs, 1996,20(8) :906.
  • 5Fu Chunxiao, Chen Changzhi, Yu Yaoting. Heat-aggregated human IgGRF as immunosorbent for rheumatoid arthritis[J]. Art Cells Blood Sub and Immob Biotech, 1998,26(4):367-375.
  • 6Fu Chunxiao, Chen Changzhi, Yu Yaoting. A novel immunoadsorbent for rheumatoid arthritis therapy [J]. Art Cells, Blood Sub and Immob Biotech, 2000,28(5):409-414.
  • 7Masatoshi Sagimoto, Minoru Morimoto, Hitoshi Sashiwa, et al. Preparation and characterization of water-soluble chitin and chitosan derivatives[J].Carbohydrate Polymers, 1998,36 (2) : 49.
  • 8Yamazaki Z, Idezuki Y, Inone N, et al. Extracorporeal immunoadsorption with IM-PH or IM-TR column[J].Artificial Cells and Artificial Organs, 1989,17(2):118.
  • 9Epstein W W, Sweat F W. Dimethyl sulfoxides oxidations[J].Chemical Reviews, 1967,67 (3) : 247.

同被引文献3

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部